Cellular metabolism enhancement

Cellular metabolism enhancement" refers broadly to approaches or processes that increase the metabolic activity of cells, often aiming to boost energy production, biosynthesis, or cellular repair. In a therapeutic context, these strategies target various metabolic pathways—such as glycolysis, oxidative phosphorylation, and fatty acid synthesis—to promote recovery (e.g., tissue repair after injury or aging), modulate immune responses, or, conversely, are exploited by cancer cells to support growth and therapeutic resistance. There is no single molecule or receptor known as "cellular metabolism enhancement"; rather, this term encompasses multiple targets, including enzymes (e.g., hexokinase, pyruvate kinase), transporters, and regulators of metabolic flux. Drugs like metformin can indirectly enhance or modulate cellular metabolism, often via mitochondrial effects and induction of mitophagy, while glycolysis inhibitors may suppress excessive metabolic activity in cancer therapy contexts. Due to its non-specific nature and broad application, "cellular metabolism enhancement" is not a recognized molecular or pharmacological target but rather a conceptual or functional category in biomedical research[1][2][3][4][5].

Modulation of central energy metabolism (glycolysis, oxidative phosphorylation, fatty acid synthesis, glutaminolysis); Mitochondrial function modulation and mitophagy activation; Regulation of metabolic enzyme activity (e.g., targeting hexokinase, pyruvate kinase M2, glutaminase)